As of November 27, CRISPR Therapeutics AG (NASDAQ:CRSP) has a moderately positive opinion, with 60% analysts covering it having a Buy or equivalent rating. With a consensus 1-year median price target ...
20h
Lyme disease often goes undetected when it's most treatable. These teens are working to change that.
Teens at a Georgia high school may have come up with a better way to detect and treat Lyme disease. They took their idea to ...
But sometimes, this top investor who focuses on innovation does see eye-to-eye with analysts, and the perfect example of this ...
Highlighting 10 innovative late-stage BioPharma drugs with the potential to reshape treatment paradigms and industry dynamics ...
5d
A New Way of Stopping High Cholesterol Sounds Like Sci-Fi. Doctors Call it the "Future of Medicine."
New research breaks down how scientists use CRISPR technology to lower cholesterol. The cholesterol-lowering effects could be permanent.
Higher yields, greater resilience to climatic changes or diseases—the demands on crop plants are constantly growing. To ...
AZoLifeSciences on MSN
Neurons and Other Nondividing Cells Respond Differently to CRISPR-Cas9 Gene Editing
The gene editing tool known as CRISPR-Cas9 is changing what's possible for treating a wide range of diseases caused by ...
The gene editing tool known as CRISPR-Cas9 is changing what's possible for treating a wide range of diseases caused by ...
In a major step forward for cancer care, researchers at ChristianaCare’s Gene Editing Institute have shown that disabling the NRF2 gene with CRISPR technology can reverse chemotherapy resistance in ...
A major medical milestone took place in May 2025, when doctors at the Children’s Hospital of Philadelphia used CRISPR-based gene editing to treat a child with a rare genetic disorder. Unlike earlier ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback